IL1B and Alzheimer disease: Extracellular Aβ deposition activates innate immunity by binding to pattern recognition receptors, leading to numerous inflammatory mediators (e.g., nitric oxide and reactive oxygen species) and cytokines (e.g., IL-1β, IL-10, IL-33, and TNF-α), and contributing to the development of AD[4].